OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, provides an update to ...

Tevard Biosciences, Inc., a privately held biotechnology company pioneering tRNA-based therapies to cure a broad range of ...

When it comes to evolution, there is a need to be proactive, envisage the kind of evolution required and go after it very ...

VectorY Therapeutics, a biotechnology company developing innovative vectorized antibody therapies for the treatment of ...

Interview: From powering 95M TPS to pioneering vector search, Aerospike CTO Srini Srinivasan reveals how real-time data is ...

Oxford Biomedica said in an update on Wednesday that it remains on track to meet its full-year guidance as outlined in its ...

Since the approval of Luxturna, there has been a wave of gene therapies advancing in clinical trials to treat genetic vision ...

The company highlights the evolution of its aircraft design, momentum in its testing program and the continued development of ...

In this newly created role, Atkinson will partner with the Chief Executive Officer and management team to develop long-term business and commercial strategies that support company growth ...

It’s no secret, and hasn’t been for some time, that identity is the preferred attack vector for cyber criminals and ...

With monsoon season round the corner, the state’s Health and Family Welfare Department has geared up its machinery to contain ...